Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4841657

Brc1cnc2[nH]c(-c3ccc(NCc4ncc[nH]4)cc3)nc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.41
FPR2 P25090 1/20 0.40
KLK1 P06870 1/20 0.39
KLK5 Q9Y337 1/20 0.39
MMP2 P08253 5/20 0.36
MMP9 P14780 5/20 0.36
MMP8 P22894 5/20 0.36
MMP13 P45452 5/20 0.36
HPSE Q9Y251 3/20 0.36
CYP1A2 P05177 2/20 0.34
TSHR P16473 1/20 0.34
HDAC6 Q9UBN7 2/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33
HDAC1 Q13547 1/20 0.33
AURKA O14965 1/20 0.33
RPS6KB1 P23443 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842422 0.91 TAAR1 (0.47) TAAR1FPR2KLK1KLK5MMP2
Trifluoroacetic Acid SCHEMBL4844134 0.84 HPSE (0.36) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4845870 0.84 TAAR1 (0.41) TAAR1HPSEFNTAFNTBPGGT1B
Trifluoroacetic Acid SCHEMBL4838956 0.83 SCD (0.42) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4845670 0.83 FFAR1 (0.42) HPSEHDAC1
Trifluoroacetic Acid SCHEMBL5259763 0.83 MMP2 (0.35) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4841466 0.82 NPC1 (0.35) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4834343 0.82 MAP3K8 (0.35) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4838725 0.82 MMP2 (0.34) MMP2MMP9MMP8MMP13HPSE
Trifluoroacetic Acid SCHEMBL4846619 0.82 MMP2 (0.35) MMP2MMP9MMP8MMP13HPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 TAAR1 2145/4885FPR2 3285/4885KLK1 1767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.